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a  b  s  t r  a  c  t
Purpose:  To compare  intravoxel  incoherent  motion  (IVIM)  diffusion-weighted  imaging  (DWI)  of  the  liver
between  1.5  T and  3.0  T in terms  of parameter  quantiﬁcation  and  inter-platform  reproducibility.
Materials  and  methods:  In this  IRB  approved  prospective  study,  19 subjects  (17  patients  with  chronic  liver
disease  and  2  healthy  volunteers)  underwent  two repeat  scans  at 1.5 T and  3.0  T. Each scan  included
IVIM  DWI  using  16  b values  from  0 to 800  s/mm2.  A single  observer  measured  IVIM  parameters  for  each
platform  and  estimated  signal  to noise  ratio  (eSNR)  at b0,  200,  400  and  800  s/mm2. Wilcoxon  paired  tests
were  used  to  compare  liver eSNR  and  IVIM parameters.  Inter-platform  reproducibility  was  assessed  by
calculating  within-subject  coefﬁcient  of  variation  (CV)  and  Bland–Altman  limits  of agreement.  An  ice
water  phantom  was  used  to test  ADC  variability  between  the two MRI systems.
Results:  The  mean  invitro  difference  in  ADC  between  the two  platforms  was  6.8%.  eSNR  was  signiﬁcantly
higher  at  3.0T  for  all selected  b values  (p = 0.006–0.020),  except  for  b0 (p = 0.239).  Liver  IVIM parameters
were  signiﬁcantly  different  between  1.5  T and  3.0  T (p =  0.005–0.044),  except  for  ADC  (p  =  0.748).  The
inter-platform  reproducibility  of  true  diffusion  coefﬁcient  (D) and  ADC  were  good,  with  mean  CV of
10.9%  and  11.1%,  respectively.  Perfusion  fraction  (PF)  and  pseudodiffusion  coefﬁcient  (D*)  showed  more
limited  inter-platform  reproducibility  (mean  CV  of  22.6%  for  PF  and  46.9%  for D*).
Conclusion:  Liver  D and  ADC  values  showed  good  reproducibility  between  1.5 T and 3.0  T  platforms;  while
there  was  more  variability  in PF,  and  large  variability  in  D*  parameters  between  the  two  platforms.  These
ﬁndings  may  have  implications  for drug  trials  assessing  the role  of  IVIM  DWI  in tumor  response  and  liver
ﬁbrosis.
© 2015  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND. Introduction
Diffusion weighted imaging (DWI) provides information about
he functional environment of water in tissues by detecting the
andom microscopic motion of free water molecules known as
rownian motion. DWI  of the liver has shown promise for tumor
etection, characterization, for the prediction and assessment of
esponse to therapy, and for detection of liver ﬁbrosis and cir-
hosis [1–5]. Intravoxel incoherent motion (IVIM) DWI  separates
iffusion and perfusion effects [6]. Because blood perfusion in
Abbreviations: ADC, apparent diffusion coefﬁcient; D, true diffusion coefﬁcient;
*,  pseudo diffusion coefﬁcient; DWI, diffusion-weighted imaging; IVIM, intravoxel
ncoherent motion.
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chronic liver disease is an important surrogate marker for the
severity of liver ﬁbrosis [7], IVIM could be more sensitive than
conventional DWI  in characterizing liver ﬁbrosis. Luciani et al. [8]
used a 10 b values IVIM DWI  sequence at 1.5 T and suggested
that restricted diffusion observed in patients with cirrhosis were
mainly related to decreased velocity of capillary blood [pseudod-
iffusion coefﬁcient (D*)]. These results were conﬁrmed by Patel
et al. [4], who additionally demonstrated that a signiﬁcant decrease
in liver static tissue molecular diffusion [true diffusion coefﬁcient
(D)], perfusion-related pseudodiffusion [perfusion fraction (PF) and
pseudodiffusion coefﬁcient (D*)] in patients with cirrhosis when
compared with subjects with noncirrhotic liver. Subsequently, sim-
ilar results were reported by Dyvorne et al. [9]. Most of these
previous IVIM DWI  studies of liver were performed using 1.5T plat-
forms. There is a growing interest in performing DWI  at 3.0 T, which
has the advantage of higher signal to noise ratio (SNR) compared to
1.5 T [10–13]. The effect of 3.0 T on quantitative diffusion param-
eters in the abdomen in comparison with 1.5 T has been rarely
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escribed [14,15]. Rosenkrantz et al. [14] reported similar ADC val-
es in the liver using 1.5 T and 3.0 T, while Dale et al. [15] reported
igniﬁcant ﬁeld dependent differences in liver ADC. Knowledge of
nter-platform variability in ADC and IVIM parameters may  have
mplications for prospective drug trials assessing tumor response
o therapy.
To our knowledge, there is no published comparison on the
ffects of ﬁeld strength in liver IVIM parameters. This is important
or the validation of quantitative diffusion metrics for response to
herapy and for drug trials.
The purpose of this study was to compare 1.5 T and 3.0 T in terms
f inter-platform variability in liver IVIM parameters.
. Materials and methods
.1. Phantom study
A phantom study was performed to test the calibration of ADC
alues at 1.5 T and 3.0 T. The phantom consisted of a center tube
lled with distilled water surrounded by ice water, as described
ecently [16]. DWI  sequence parameters are detailed in Table 1.
.2. Subjects
This HIPAA compliant prospective study was funded by––and
pproved by our local Institutional Review Board. Informed signed
onsent was obtained from all participants. Seventeen patients
ith liver disease (M/F 12/5, mean age 58 y, range 30–69 y) were
nrolled in the study from March 2012 to Jan 2013. Fourteen
atients had viral hepatitis C and 3 had NASH. Liver ﬁbrosis was
roven by histopathology in 16 patients. In addition, 2 healthy vol-
nteers (2 males, age 30 and 38 y) without history of liver disease
ere recruited for the study.
. IVIM DWI
Each subject underwent two DWI  scans, consisting of one scan
n a 1.5 T platform (Magnetom Avanto, Siemens Healthcare) with
 multichannel spine and body matrix coil and another scan on a
.0T platform (Discovery MR  750; GE Healthcare) with a 32-channel
hased array body coil (the same platforms were used for phan-
om study). The 1.5 T and 3.0 T scans occurred with a mean delay
f 9 days (range, 0–45 days). All subjects were asked to fast for 6 h
efore the study. DWI  acquisition was performed before contrast
njection (in patients). A respiratory triggered (RT) DWI  acquisition
as used with a navigator at the 1.5 T (2D PACE: prospective acqui-
ition correction, Siemens Healthcare) [17,18] and a free breathing
WI acquisition was used at 3.0 T (Table 1). DWI  acquisition plane
rientation was chosen according to the contrast imaging orien-
ation of that subject. Axial acquisition was obtained at 3.0 T due
o decreased distortion compared to coronal acquisition. Coronal
cquisition was obtained in 13 subjects at 1.5 T, the rest having axial
cquisition. Coronal orientation was chosen in order to match the




An observer (observer 1—an MR  physicist with 3 years of post-
octoral experience) reviewed DWI  images of the phantom by
sing OsiriX (v.4.1.2, Pixmeo, Switzerland). An oval region of inter-
st (ROI) of area 2 cm2 was manually deﬁned on the central slice
hrough the central liquid water of the phantom to measure signal
ntensity (SI). ADC calculation was performed by least squares ﬁt-iology Open 2 (2015) 123–128
ting of Eq. (1), where Sb is the signal intensity for each b value and
S0 is the signal intensity at a b value of zero:
ln(Sb) = ln(S0)−bADC. (1)
3.1.2. In vivo data
Another observer (observer 2—with 6 years experience in Body
MRI) performed quantitative analysis of diffusion images. Five cir-
cular ROIs were placed manually within the right hepatic lobe on
5 consecutive slices centered on the main portal vein. The area of
each ROI ranged from 6 to 9 cm2. Care was taken to avoid large ves-
sels and blurred regions in ROI placement. The left hepatic lobe was
not assessed due to the possibility of cardiac motion artifacts. The
same ROI mask was  propagated to all b values. The DWI  images of
two scans (at 1.5 T and 3.0 T) for each subject were viewed simulta-
neously, with ROIs placed in as similar location as possible between
scans. If the acquisition planes for one subject were different at two
scans, measurements were done on coronally reformatted images
of axial acquisition. Signal intensity (SI) of each pixel within each
ROI was measured (Fig. 1), and the values of pixels within ﬁve ROIs
(from ﬁve adjacent slices) were averaged for biexponential ﬁtting.
To examine the individual contributions of true molecular diffusion
and incoherent motion of water molecules in the capillary network
to the apparent diffusion changes, the mean SI in the ROI  was ﬁt-
ted to the IVIM Eq. (2) (Fig. 1), where the SI decay with increasing
b values as a fast pseudo-diffusion of constant D* (pseudodiffu-
sion coefﬁcient) for the intravascular water fraction PF (perfusion
fraction), and a slow molecular diffusion constant D (true diffusion
coefﬁcient), for the nonﬂowing spins [6]. SIb is the signal intensity
(SI) at an arbitrary b value. SI0 is the SI in the absence of diffusion
weighting (b = 0 s/mm2).
SIb = SI0{PFe−bD∗ + (1 − PF)e−bD} (2)
A Bayesian ﬁtting method was used to estimate liver IVIM
parameters [9,19]. The ﬁtting method was implemented with in-
house software programmed in Matlab (Matlab 2011a, MathWorks,
Natick, MA,  USA). In addition, mean liver ADC of each subject
was obtained by using 16 b values of 0–800 s/mm2 with mono-
exponential least squares ﬁt using Eq. (1). The mean ROI  SI of each
b value was used to ﬁtting the ADC.
Finally, estimated signal-to-noise ratio (eSNR) was  calculated
for 4 selected b-values (0, 200, 400 and 800 s/mm2) as follows:
eSNR = SImean/SDnoise, where SImean is mean SI of all ROIs, SDnoise
is standard deviation of background noise (measured on a small
ROI outside the signal region).
3.2. Statistical analysis
SPSS 16.0 (SPSS Inc., Chicago, IL, USA) was  used for all compu-
tations. A series of related samples Wilcoxon tests were used to
compare eSNR, IVIM parameters and ADCs between 1.5 T and 3.0 T
datasets. To evaluate inter-platform agreement of IVIM parame-
ters and ADCs, the within-subject coefﬁcient of variation (CV) and
Bland–Altman limits of agreement were computed.
4. Results
4.1. Phantom study
The diffusion signal of the phantom showed a mono-exponential
decay with increasing b values for each platform. The mean ADC val-
ues computed with 16 b values for 1.5 T and 3.0 T were 1.13 ± 0.03
and 1.21 ± 0.02 (×10−3 mm2/s), respectively. The mean difference
of ADCs between the two platforms was  6.8%.
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Table  1
Sequence parameters used for 1.5 T and 3.0 T IVIM DWI  sequences.
Platform 1.5 T 3.0 T 1.5 T 3.0 T
Study type In vivo Phantom
Acquisition plane Coronal/Axial Axial Coronal
Acquisition scheme PACE Free breathing – –
TR  1 respiratory cycle 2600 3000 2600
TE  74 59.5 74 58.3
b-Values (s/mm2) 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 175, 200, 400, 600, 800
Diffusion directions 3
Field of view (mm) 350–400
Slice/interval thickness (mm) 8.0/1.6
Number of slices 15 20–26 13
Parallel imaging factor 2
Number of averages 2 2 2 2
Acquisition matrix 160 × 128 128 × 128 160 × 128 128 × 128
Average scan time (min) 7–12 3:45 2:22 3:45
Fig. 1. 43-year-old male patient with HCV. SS EPI diffusion-weighted images acquired at 1.5 T and 3.0 T. (A–C): 1.5 T coronal DWI  images [b = 200 (A), 400 (B), 800 (C)]. (D–F):
3.0T  axial DWI  images [b = 200 (D), 400 (E), 800 (F)]. (G): Coronal DWI  image (b = 200) reformatted from axial acquisition at 3.0T. (A) and (G) show ROI  placement for signal
intensity measurement. ROIs with the same size were placed within the right hepatic lobes as similar location as possible between scans. (H): Graph shows liver SI decay
with  16 b values acquired at 1.5 T () and 3.0 T (). For display purposes, data were normalized to b0 SI. Dashed (1.5 T) and solid (3.0 T) lines are biexponential model curves
using  Bayesian estimated IVIM parameters Calculated values were D (true diffusion coefﬁcient) = 1.19 and 0.96 × 10−3 mm2/s, PF (perfusion fraction) = 13.6% and 10.4% and
D*  (pseudo-diffusion coefﬁcient) = 82.3 and 41.9 × 10−3 mm2/s at 1.5 T and 3.0 T, respectively.
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Fig. 2. Bland–Altman plots of percentage difference (y-axis) against mean (x-axis) of D (A), PF (B), D* (C) and ADC (D) measurements at the 1.5 T and 3.0 T, with mean
percentage difference and upper and lower limits of agreement (also refer to Table 3).
Fig. 3. 66-year-old male patient with HCV and Metavir stage 1 ﬁbrosis. Parametric IVIM diffusion maps of the abdomen at 1.5 T (Coronal, A–D) and 3.0T (axial, E–H). A, E:
SS  EPI diffusion image (b200). (B and F): D map (true diffusion coefﬁcient, mm2/s). (C and G): PF map (perfusion fraction, %). (D and H): D* map (pseudodiffusion coefﬁcient
mm2/s). D maps show slightly higher values at the 1.5 T than the 3.0 T. D* maps show higher values at the 1.5 T compared to the 3.0 T. PF maps show lower values at the 1.5 T
compared to the 3.0 T. Calculated values were as follows: for D, 0.97 and 0.94 × 10−3 mm2/s at the 1.5 T and the 3.0 T, respectively; for PF, 18.9% and 27.7%, respectively; for
D*,  82.9 and 60.3 × 10−3 mm2/s, respectively.
Y. Cui et al. / European Journal of Rad
Table  2
Estimated liver SNR of the 4 selected b value images acquired at 1.5 T and 3.0 T.
b value 1.5 T 3.0 T p
b0 81.7 ± 65.7 93.5 ± 81.0 0.239
b200 55.6 ± 34.4 83.1 ± 69.9 0.020












































Pb800 29.5 ± 17.9 49.7 ± 39.8 0.006
ote: data are mean ± standard deviation.
.2. In vivo study
There was a trend toward lower eSNR at increasing b values at
oth 1.5 T and 3.0 T. The eSNRs of DWI  images at 3.0 T were higher
ompared to 1.5 T, reaching signiﬁcance at b = 200, 400 and 800 but
ot at b = 0 (Table 2).
There were signiﬁcant differences between platforms for D
p = 0.005), PF (p = 0.033) and D* (p = 0.044). D and D* were higher
t 1.5 T compared to 3.0 T, while PF was lower at 1.5 T compared to
.0 T. There was no signiﬁcant difference in ADC between 1.5 T and
.0 T (p = 0.748) (Table 3).
The mean CVs between the two platforms varied from 10.9% to
6.9% (Table 3). Bland–Altman plots of the intra platform repeata-
ility of IVIM parameters and ADC measurements for the liver
arenchyma are shown in Fig. 2. A total of 94.7% (18/19) of data
oints were within the limits of agreement for each of the D, PF
nd ADC. All the data points (19/19) of D* were within the limits of
greement. Fig. 3 shows examples of parametric maps at 1.5 T and
.0 T.
. Discussion
Recently, DWI  has been increasingly investigated in the liver
nd has shown potential for the detection of liver ﬁbrosis and cir-
hosis [1,20,21] and for assessment of focal liver lesions [1,2,22].
ith the advantage of separation of true diffusion from perfu-
ion effects, IVIM DWI  showed better diagnostic performance for
etection of liver ﬁbrosis [10,23]. Although these results indicated
he potential of IVIM DWI  as a quantitative tool of liver ﬁbrosis,
he widespread application of this method is still limited for lack
f uniform acquisition and processing methods. It is difﬁcult to
et a reliable uniform criterion from results of different studies
cquired with MR  platforms at different ﬁeld strengths without the
nowledge of intra-platform reproducibility. Further validation of
VIM DWI  comparability between different platforms—particularly
uantitative assessment of the IVIM parameters is one of the major
rerequisite for the IVIM parameters development as an imaging
iomarker for liver ﬁbrosis and for cancer drug trials.
The physical properties of water were well characterized previ-
usly [16,24]. In our study, to assess quantitative agreement across
he two platforms, an ice water phantom study was applied ﬁrst.
he ADC value measured in our study for the ice water at 1.5 T was
.13 × 10−3 mm2/s, which was within 3% of the literature value of
.1 × 10−3 mm2/s [25], while the ADC value of ice water at 3.0 T
n our study was 1.21 × 10−3 mm2/s that was within about 9% of
able 3
iver IVIM parameters and ADC at 1.5 T and 3.0 T, with coefﬁcients of variation (CVs) and 
Parameter 1.5 T 3.0 T 
D 1.12 ± 0.16 0.99 ± 0.16 
PF  16.0 ± 4.1 19.0 ± 5.5 
D*  93.5 ± 64.0 57.2 ± 40.2 
ADC  1.52 ± 0.18 1.48 ± 0.27 
ote: data are mean ± standard deviation.
, D* and ADC: ×10−3 mm2/s.
F: %.iology Open 2 (2015) 123–128 127
this value. These ﬁndings agree with previous published data [16],
where 86% of the ice water ADC values obtained at 20 different
human MRI  scanners from three vendors were within 5% of the lit-
erature value and all measurements were within 10% of the value.
Another recent study compared data from 35 clinical MRI  systems
form three vendors at 1.5 and 3.0 T, showed that multi-system
reproducibility for ADC of ice water are within 2.8–3.1% [24] besides
an outlier at 3.0 T with 70% higher than the literature value. The dif-
ference of ADC values between the two  platforms was  6.8% in our
study. These ﬁndings are close to those of Chenevert et al. [16],
who showed that the variation of measured ADC values between
all platforms tested was ±5%.
As a potential quantitative biomarker for liver ﬁbrosis, inter
platform reproducibility of IVIM is an important estimation of the
reliability. In our study, the mean D of liver is 1.12 × 10−3 mm2/s
at 1.5 T and 0.99 × 10−3 mm2/s at 3.0T. These ﬁndings lie within
the range of previous published data, where the D value for liver
ﬁbrosis ranged from 1.02 to 1.19 × 10−3 mm2/s at 1.5T [4,8,9] and
0.98 to 1.10 × 10−3 mm2/s at 3.0 T [10]. The mean CV of the D values
for ﬁbrosis liver was  10.9% (range from 0.6% to 34.0%) between the
1.5 and 3.0 T platforms in our study. That is similar with the inter-
platform reproducibility of the D values of ﬁbrosis liver reported
in previous studies [4,9], where mean CV ranged from 5% to 12.4%.
Moreover, our study showed the inter-platform reproducibility was
fair for PF (CV from 8.4% to 53.0%), and more limited for D* (CV from
3.3% to 104.5%). Large differences in D* may  be attributed to ﬁtting
errors, as this parameter typically displays the largest ﬁtting uncer-
tainty in IVIM studies. Our study showed good reproducibility in
liver ADC with mean CV of 11.1%. However, the application of ADC
is not recommended, because it has been shown that the degree
of signal attenuation of the liver with increasing b value is non-
linear, the monoexponential ﬁtting of ADC value is mathematically
unacceptable except when b values are larger than 100–150 s/mm2
[11]. Recent animal studies demonstrated an inverse relationship
between D values and degree of liver ﬁbrosis [26], and the D value
can reﬂect the progression of liver ﬁbrosis [23]. Taken together,
these ﬁndings seem to imply the D value might be the most appli-
cable and comparable parameter of IVIM DWI  as a biomarker of
liver ﬁbrosis between different ﬁeld strengths platforms.
Theoretically, the use of 3.0 T is ideal for DWI  due to improved
SNR compared to 1.5 T [13,27], as shown in our study. However,
3.0 T has also the disadvantages such as increased magnetic sus-
ceptibility artifact and eddy current related distortion [27]. In this
context, qualitative analysis of artifacts and image distortions was
often applied in previous ﬁeld strength related study. Most of
these studies showed that better DWI  images were acquired at
1.5 T [14,28]. Because different acquisition plane orientations and
breathing control techniques were used at the two  platforms of our
study, analysis of image quality was not applicable to our study.
Our study had some limitations. First, our study population was
relatively small. Second, our study population consisted almostments for differential ﬁbrosis liver from healthy subjects were not
assessed. Third, different acquisition orientations and breathing
control techniques were used at 1.5 T and 3.0 T in our study, which
Bland–Altman limits of agreement (BALA) between the two platforms.
p Mean CV (range, in%) BALA (%)
0.005 10.9 (0.6 − 34.0) −17.9, 43.8
0.033 22.6 (8.4 − 53.0) −82.6, 51.2
0.044 46.9 (3.3 − 104.5) −91.1, 179.6
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imited the application of qualitative image quality comparison
etween the two platforms. However, we focused on variabil-
ty of quantitative parameters instead of image quality between
latforms. Prior studies have reported good agreement between
he ADCs acquired by different breathing control techniques DWI
equences [17,18]; with moderate to excellent parameter repro-
ucibility for PF and D in IVIM of normal and ﬁbrosis liver were
ound when different breath control technique applied [9]. Thus,
e assumed that these difference acquisition protocols used in our
tudy did not diminish the reliability of our results.
In conclusion, liver D and ADC values showed good inter-
latform reproducibility between 1.5 T and 3.0 T. There was
cceptable variability on PF, and large variability in D* values
etween the two platforms. These ﬁndings may  have implications
or future drug trials and prospective studies assessing the role of
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